REALE, MARIA LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 1.735
EU - Europa 1.516
AS - Asia 1.104
OC - Oceania 41
SA - Sud America 25
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.445
Nazione #
US - Stati Uniti d'America 1.662
CN - Cina 478
IT - Italia 381
FR - Francia 369
IN - India 158
JP - Giappone 142
IE - Irlanda 138
GB - Regno Unito 122
NL - Olanda 103
DE - Germania 83
CA - Canada 58
HK - Hong Kong 56
VN - Vietnam 50
RU - Federazione Russa 43
AU - Australia 37
TW - Taiwan 37
UA - Ucraina 34
ES - Italia 32
CZ - Repubblica Ceca 30
BE - Belgio 28
KR - Corea 28
SG - Singapore 26
ID - Indonesia 19
PL - Polonia 18
IR - Iran 17
CH - Svizzera 16
GR - Grecia 16
PH - Filippine 16
SE - Svezia 16
MK - Macedonia 15
TR - Turchia 15
JO - Giordania 13
DK - Danimarca 12
UZ - Uzbekistan 12
MX - Messico 11
NO - Norvegia 11
RO - Romania 11
BR - Brasile 10
FI - Finlandia 9
CL - Cile 8
IL - Israele 7
ZA - Sudafrica 7
PT - Portogallo 6
TH - Thailandia 6
MY - Malesia 5
RS - Serbia 5
SA - Arabia Saudita 5
AT - Austria 4
CO - Colombia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
DZ - Algeria 3
SL - Sierra Leone 3
AP - ???statistics.table.value.countryCode.AP??? 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
EU - Europa 2
GT - Guatemala 2
HR - Croazia 2
HU - Ungheria 2
IQ - Iraq 2
IS - Islanda 2
LT - Lituania 2
PE - Perù 2
PS - Palestinian Territory 2
TN - Tunisia 2
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
EG - Egitto 1
HT - Haiti 1
KH - Cambogia 1
LB - Libano 1
LY - Libia 1
MA - Marocco 1
MM - Myanmar 1
MZ - Mozambico 1
PA - Panama 1
SO - Somalia 1
Totale 4.445
Città #
Dublin 133
Houston 119
Fairfield 111
Santa Cruz 102
Ashburn 82
Ann Arbor 76
Amsterdam 64
Seattle 59
Woodbridge 48
Nanjing 47
Beijing 44
Shanghai 41
Buffalo 39
Torino 39
Cambridge 38
Tokyo 34
Secaucus 33
Chicago 32
Dong Ket 31
Taipei 31
Turin 31
Jinan 30
New York 30
San Diego 27
Los Angeles 26
Milan 24
Wilmington 24
Council Bluffs 23
Guangzhou 23
Guiyang 19
Hangzhou 19
London 19
Bengaluru 18
Boardman 18
Hyderabad 18
Mysore 17
Central 16
Duncan 16
Mountain View 16
Chengdu 15
Miami Gardens 15
Chennai 14
Hefei 14
Mumbai 14
Rome 14
Seoul 14
Nanning 13
New Delhi 13
Paris 13
Bukhara 12
Walnut Creek 12
Central District 11
Changsha 11
Jakarta 11
Rochester 11
Saint-Michel 11
San Francisco 11
Brisbane 10
Indianapolis 10
Ottawa 10
Amman 9
Changchun 9
Las Vegas 9
Odesa 9
Padova 9
San Jose 9
Skopje 9
Toronto 9
Verona 9
Xian 9
Bologna 8
Brussels 8
Fontenay-sous-bois 8
Helsinki 8
Naples 8
Pisa 8
Wuhan 8
Columbus 7
Copenhagen 7
Lake Forest 7
Singapore 7
Barcelona 6
Fremont 6
Hanoi 6
Hartford 6
Henderson 6
Napoli 6
Piemonte 6
Taintignies 6
Takamatsu 6
Warsaw 6
Atlanta 5
Bethnal Green 5
Boston 5
Boulder 5
Chongqing 5
Clearwater 5
Kolkata 5
Krakow 5
Manila 5
Totale 2.155
Nome #
Oncological Procedures and Risk Assessment of COVID-19 in Thoracic Cancer Patients: A Picture From an Italian Cancer Center, file e27ce434-a293-2581-e053-d805fe0acbaa 867
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients, file e27ce431-470d-2581-e053-d805fe0acbaa 611
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics, file e27ce431-d7ce-2581-e053-d805fe0acbaa 510
Osimertinib-induced Cardiac Dysfunction in EGFRMutated Lung Cancer: A Case Series of Five Patients, file e27ce42d-b323-2581-e053-d805fe0acbaa 322
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018, file e27ce42f-7380-2581-e053-d805fe0acbaa 247
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave, file e27ce431-36e2-2581-e053-d805fe0acbaa 189
Repositioning PARP inhibitors in the treatment of thoracic malignancies, file e27ce432-5f29-2581-e053-d805fe0acbaa 187
Quality of life in patients with lung cancer: the way forward, file e27ce431-a47e-2581-e053-d805fe0acbaa 170
18F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and Survival, file e27ce42f-d711-2581-e053-d805fe0acbaa 144
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016, file e27ce42d-d0be-2581-e053-d805fe0acbaa 141
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma, file e27ce435-141e-2581-e053-d805fe0acbaa 137
Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?, file e27ce431-6018-2581-e053-d805fe0acbaa 119
SELECTing adjuvant treatment in early stage epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer, file e27ce42e-acaf-2581-e053-d805fe0acbaa 94
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018, file e27ce42e-ac1e-2581-e053-d805fe0acbaa 83
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease, file e27ce430-a2d3-2581-e053-d805fe0acbaa 82
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features, file e27ce432-0a06-2581-e053-d805fe0acbaa 76
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit, file e27ce430-3392-2581-e053-d805fe0acbaa 74
Epidermal growth factor receptor exon 20 insertion variants in non-small cell lung cancer patients, file e27ce435-06a5-2581-e053-d805fe0acbaa 71
Resistance to anaplastic lymphoma kinase inhibitors: Knowing the enemy is half the battle won, file e27ce431-c7d9-2581-e053-d805fe0acbaa 58
Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: Are we actually ready?, file e27ce431-2e7f-2581-e053-d805fe0acbaa 57
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients, file e27ce42f-58c4-2581-e053-d805fe0acbaa 55
Clinical and molecular features of epidermal growth factor receptor (Egfr) mutation positive non‐small‐cell lung cancer (nsclc) patients treated with tyrosine kinase inhibitors (tkis): Predictive and prognostic role of co‐mutations, file e27ce431-f183-2581-e053-d805fe0acbaa 54
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements, file e27ce435-6509-2581-e053-d805fe0acbaa 51
LATITUDE and other coordinates in quality of life of prostate cancer patients, file e27ce432-7aa9-2581-e053-d805fe0acbaa 40
Immune-checkpoint inhibition in stage III unresectable NSCLC: Challenges and opportunities in the post-PACIFIC era, file e27ce431-d7d0-2581-e053-d805fe0acbaa 36
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review, file e27ce435-747f-2581-e053-d805fe0acbaa 32
Dealing with NSCLC EGFR mutation testing and treatment: a comprehensive review with an Italian real-world perspective, file e27ce431-9132-2581-e053-d805fe0acbaa 14
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer, file da5de55f-f3c4-4f0c-9ea1-6482648974b4 13
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements, file e27ce435-0c9b-2581-e053-d805fe0acbaa 13
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018, file e27ce42e-7da3-2581-e053-d805fe0acbaa 7
68 Ga-PSMA Uptake in Fibrous Dysplasia, file e27ce42e-90db-2581-e053-d805fe0acbaa 7
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer center, file 56d24ef4-1e70-4c3d-af78-a4a730104246 6
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program, file 2411ef4a-6c8f-4b69-b231-243bf720e585 5
The KEY for chemo-immunotherapy combination: Taking NOTEs from squamous cell lung cancer, file 33363783-6e49-4fb2-86f7-bde33f6dcb08 4
Quality of life in patients with lung cancer: the way forward, file e27ce431-358e-2581-e053-d805fe0acbaa 2
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database, file 75c1b3e2-d1f6-46de-989a-96ff04f7952f 1
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review, file e27ce431-dd16-2581-e053-d805fe0acbaa 1
Totale 4.580
Categoria #
all - tutte 6.617
article - articoli 0
book - libri 0
conference - conferenze 1.176
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201916 0 0 0 0 0 0 0 0 0 0 9 7
2019/2020244 2 7 1 17 19 20 15 24 34 28 49 28
2020/2021615 25 17 22 10 22 16 13 52 107 123 75 133
2021/20221.845 189 121 120 224 213 115 177 125 130 136 205 90
2022/20231.121 81 98 149 138 73 82 65 77 57 45 61 195
2023/2024718 31 53 44 58 63 39 227 103 35 56 9 0
Totale 4.580